文献速递衰弱、肌少症与跌倒老年综合评估

住院老年患者肌肉功率改善的临床意义阈值及其功能相关性

Identifying Clinically Meaningful Muscle Power Enhancements and Their Functional Correlates in Hospitalized Older Patients.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2024-01-01

该研究基于两项随机临床试验的302例老年住院患者(平均86.7岁),分析多组分运动干预后肌肉功率与力量提升与功能改善(SPPB和步速)的关联。结果显示,SPPB和步速应答者的肌肉功率提升显著更大,基于SPPB和步速的临床有意义功率改善阈值为30.2%至48.7%,而1RM基于步速的阈值为8.2%。

要点

  • SPPB应答者30%1RM相对功率提升83.5% vs 34.8%,绝对33.0 vs 12.8 W。
  • 步速应答者30%和60%1RM功率及1RM绝对增益均显著更大。
  • 基于SPPB和步速的临床有意义功率改善阈值为30.2%至48.7%。

核心结论

  • 肌肉功率增益在SPPB和步速改善的患者中最明显,提示功率对功能恢复的关键作用。

研究设计与样本

  • 汇总2项随机临床试验的302例老年住院患者(干预组169例,对照组133例,平均年龄86.7岁)。
  • 干预为包含功率训练、平衡和步态训练的多组分运动方案,连续3至6天。
  • 采用锚定法将肌肉功能提升与SPPB和步速关联以定义临床有意义改善。

主要发现

  • 干预组中SPPB应答者与非应答者30%1RM相对功率提升83.5% vs 34.8%,绝对33.0 vs 12.8 W(p < .05)。
  • 60%1RM相对功率提升61.1% vs 22.4%(p < .05)。
  • 步速应答者在30%和60%1RM的相对和绝对最大功率提升均显著大于非应答者(p < .05)。
  • 步速应答者1RM绝对增益21.2 vs 15.2 kg(p < .05)。

关键数值与推荐

  • 基于SPPB和步速的临床有意义肌肉功率改善阈值为30.2%至48.7%。
  • 基于步速的1RM临床有意义改善阈值为8.2%。

临床怎么用

  • 在急性期老年住院患者中实施含功率训练的多组分运动,可优先关注功率提升以促进功能恢复。
  • 评估干预效果时,可参考30.2%至48.7%的功率改善阈值判断临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to determine the threshold of muscle power and strength enhancements that lead to functional gains after exercise intervention in an acute care unit. METHODS: A total of 302 older patients (intervention: 169, control: 133) from 2 randomized clinical trials were included (mean age: 86.7 years). We measured maximal strength (1RM) and muscle power via a velocity transducer during leg press exercise at 30% and 60% of 1RM. A multicomponent exercise program, including power training, balance, and gait exercises performed over 3 to 6 consecutive days, served as the intervention. We used an anchor-based method to correlate muscle function increases with the Short Physical Performance Battery (SPPB) and gait velocity (GVT) to define clinically meaningful improvements. RESULTS: In the intervention group, marked differences were found in maximal power at 30% of 1RM between SPPB responders and nonresponders (relative 83.5% vs 34.8%; absolute 33.0 vs 12.8 W; p < .05) and at 60% of 1RM (relative 61.1% vs 22.4%; p < .05). GVT responders demonstrated significantly greater improvements in both relative and absolute maximal power than nonresponders at both 30% and 60% of 1RM (p < .05), as well as greater absolute 1RM gains (21.2 vs 15.2 kg, p < .05). Clinically meaningful improvements for muscle power based on SPPB and GVT ranged from 30.2% to 48.7%, whereas for 1RM, it was 8.2% based on GVT. CONCLUSIONS: Muscle power gains were most notable in patients with improvements in the SPPB and GVT, highlighting the critical role of muscle power in functional recovery in these patients.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Cadore EL, Izquierdo M, Martínez-Velilla N, et al. Identifying Clinically Meaningful Muscle Power Enhancements and Their Functional Correlates in Hospitalized Older Patients. J Gerontol A Biol Sci Med Sci. 2024. PMID: 39329896. doi:10.1093/gerona/glae240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。